Schechter Investment Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.67M Sell
30,088
-3,830
-11% -$207K 0.14% 145
2024
Q4
$1.64M Sell
33,918
-367
-1% -$18.7K 0.13% 157
2024
Q3
$1.98M Sell
34,285
-1,790
-5% -$96.6K 0.15% 140
2024
Q2
$1.75M Sell
36,075
-12,184
-25% -$588K 0.13% 143
2024
Q1
$2.35M Buy
48,259
+3,003
+7% +$147K 0.18% 107
2023
Q4
$2.25M Buy
45,256
+2,593
+6% +$127K 0.19% 99
2023
Q3
$2.29M Sell
42,663
-1,159
-3% -$61.8K 0.22% 85
2023
Q2
$2.36M Sell
43,822
-6,101
-12% -$328K 0.21% 89
2023
Q1
$2.72M Buy
49,923
+2,069
+4% +$101K 0.25% 74
2022
Q4
$2.32M Buy
47,854
+1,368
+3% +$60K 0.21% 94
2022
Q3
$1.77M Sell
46,486
-17,451
-27% -$778K 0.17% 119
2022
Q2
$3.2M Sell
63,937
-62
-0.1% -$3.29K 0.31% 44
2022
Q1
$3.29M Buy
63,999
+1,904
+3% +$98.3K 0.31% 50
2021
Q4
$3.11M Buy
+62,095
New +$3.07M 0.28% 61

Other funds holding SNY

Schechter Investment Advisors's SNY Position: Q1 2025 in Review

Schechter Investment Advisors reduced its Sanofi (SNY) stake by 11% in Q1 2025, selling an estimated $207K and leaving 30,088 shares worth $1.67M. The position accounts for 0.14% of the portfolio, ranked #145.

Schechter Investment Advisors first reported a position in SNY in Q4 2021 and has held it in 14 quarters since. The position peaked at $3.29M in Q1 2022. 771 funds tracked by Wall St. Rank hold SNY as of Q1 2025.

  • Schechter Investment Advisors held 30,088 shares of Sanofi worth $1.67M as of Q1 2025.
  • Schechter Investment Advisors sold 3,830 Sanofi shares in Q1 2025, an estimated $207K.
  • Sanofi made up 0.14% of Schechter Investment Advisors's portfolio in Q1 2025, its #145 holding.
  • Schechter Investment Advisors first reported a position in Sanofi in Q4 2021 and has held it in 14 quarters since.
  • Schechter Investment Advisors's Sanofi position peaked at $3.29M in Q1 2022.
  • 771 funds tracked by Wall St. Rank held Sanofi as of Q1 2025.

Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.